Analgesics in Uruguay
The COVID-19 pandemic contributed to growing levels of health consciousness in Uruguay, with consumers seeking better and preventive health care. Acetaminophen, commonly known as paracetamol, recorded rapid growth during the COVID-19 pandemic, as consumers sought to relieve the symptoms of the virus. Demand was fuelled by the government initially recommending the use of acetaminophen, rather than ibuprofen, to treat the symptoms of COVID-19. In addition, since the start of the COVID-19 vaccinati...
Euromonitor International's Analgesics in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Analgesics in Uruguay
- Euromonitor International
- September 2022
- List Of Contents And Tables
- ANALGESICS IN URUGUAY
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Acetaminophen continues to benefit from its status as the go-to treatment to relieve symptoms of COVID-19
- Sluggish growth for ibuprofen, in view of lingering consumer health concerns
- Bayer loses share following continuing consumer shift towards acetaminophen .
- PROSPECTS AND OPPORTUNITIES
- Acetaminophen will continue to grow, albeit at a slower rate, supported new product launches and lower prices
- Demand for adult ibuprofen and adult aspirin expected to recover, amid a shift back to self-mediation
- Infrastructure improvements offer strong growth potential for e-commerce
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2017-2022
- Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
- Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
- Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN URUGUAY
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook